ask="3.86"
ask_size="500"
average_daily_volume="47898"
bid="0.97"
bid_size="200"
book_value="0.81"
change="+0.00"
change_from_200_day_moving_average="-0.30"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-2.39"
change_From_52_week_low="0.33"
change_in_percent="+0.00%"
close="1.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2446000"
high="1.61"
high_52_weeks="3.94"
last_trade_date="1/17/2017"
last_trade_price="1.55"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.55"
low_52_weeks="1.22"
market_capitalization="17.03M"
moving_average_200_day="1.85"
moving_average_50_day="1.56"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-16.40%"
percent_change_from_50_day_moving_average="-0.89%"
percent_change_from_52_week_high="-60.66%"
percent_change_from_52_week_low="+27.05%"
previous_close="1.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.91"
price_per_sales="4.48"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="27582"
weeks_range_52="1.22 - 3.94"
